UBC

Meet Jim Shamp, who serves as Vice President of Data Intelligence and Program Analytics at UBC. Mr. Shamp plays a critical role in ensuring safe and effective access to important pharmaceutical products. Read full bio: https://hubs.li/Q02VLRR70 Watch his presentation “Evolving REMS Landscape: Regulatory Updates & Compliance Challenges” on October 30 at 11:45 at World Drug Safety Congress Americas. #PatientsFirst #SafetyandRiskManagement #PatientSafety #REMS

Don’t miss our featured session discussing the best ways to ensure awareness and adoption of patient services! Learn more and connect with our speaker at https://hubs.li/Q02W7l2w0 #PatientsFirst #PatientSupport2024 #PatientSupport

We’re thrilled to announce a partnership with Osmind to advance the future of mental health treatment and research! This first-of-its kind partnership will bring together our Risk Evaluation and Mitigation Strategies with Osmind’s purpose-built mental health electronic health record platform to reduce REMS implementation burden, improve the quality of REMS data, and optimize safe medication use and health outcomes. Learn more about the partnership here: https://lnkd.in/euZufYeV #Osmind #PatientsFirst #Pharmacovigilance #DrugSafety #REMS #SafetyandRiskManagement

Our Safety and Risk Management team is excited to be attending World Drug Safety Congress Americas in Boston! Join us as we connect with industry leaders and share insights on the latest advancements in pharmacovigilance and patient safety. Schedule a time to meet with us. https://hubs.li/Q02QCKrv0 #PatientsFirst #WorldDrugSafety #SafetyandRiskManagement #DrugSafety

UBC will be at Copay Congress 2024, will you? Connect with our team to set up time to review our tailored, proactive affordability programs: https://hubs.li/Q02V-HFm0 #PatientsFirst #Copay2024 #Pharma #PatientServices

Connect with UBC at CNS Summit to explore opportunities to enhance your study design to ensure safe, affordable, and accessible treatments for patients. Visit [Link] to set up time with our leaders on-site in Boston. https://hubs.li/Q02S2MLP0 #PatientsFirst #CNSSummit #Evidence Development #RWE

Join UBC at ISPOR Europe 2024 to discuss how you can optimize your research with modernized study design and execution. To meet with our experts, visit https://hubs.li/Q02V-pJ-0 #PatientsFirst #ISPOREurope #RWE #Pharma

This Kidney Week, UBC Executive Director of Clinical Strategy, Bruce Smith, PharmD, shares his unique understanding of the real-world landscape in rare diseases, and the implementation of expanded access programs, in his blog, “The impact of CKD: Why better, accessible treatments and diagnostics are crucial.” Read the blog to learn who is impacted by CKD, its costs, and why research is critical: https://hubs.li/Q02VKfS60 #ASN #KidneyWeek #RWE #RealWorldEvidence #RWD #RealWorldData #PatientsFirst

Ensuring your clinical trial population accurately reflects the real-world population of product users is complex. Our experts have developed a Clinical Trial Diversity Action Plan Checklist to give you a comprehensive approach to planning and executing your strategy. https://hubs.li/Q02TGqwZ0 #PatientsFirst #ClinicalTrialDiversity #RWE #RealWorldEvidence #RWD #RealWorldData

UBC is excited to announce our attendance at the ASN annual meeting, as kidney professionals from across the globe come together to exchange knowledge and gain new insights. Meet with JB Flinders, PhD, MBA to discuss the importance of evidence development in advancing your kidney-related treatment and how UBC can help by contacting us: https://hubs.li/Q02VHFNG0 We hope to see you there. #ASN #KidneyWeek2024